Join us in Nashville for
"To Graft or Not to Graft" - February 15-16, 2019 Event Info
Greg Bosch is CEO of Geistlich Pharma NA, a leader in regenerative medicine in dental as well as Oral and Maxillofacial Surgery. Greg was previously President and CEO of PuriCore and held various leadership positions at Baxter International. Greg received his BA in Public Policy from Duke University and his MBA from DePaul University. In 2006, Greg received the Life Sciences CEO of the Year award at the Eastern Technology Council’s Enterprise Awards.